• Users Online: 71
  • Print this page
  • Email this page
Year : 2021  |  Volume : 5  |  Issue : 4  |  Page : 162-164

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 Antibodies among People Living with HIV: A Cross-sectional Study from Tripoli University Hospital

Department of Infectious Diseases, Tripoli University Hospital; Department of Medicine, The University of Tripoli, Tripoli, Libya

Correspondence Address:
Dr. Nader S Shalaka
Department of Infectious Diseases, Building 3, Ground Floor, Room 140, Tripoli University Hospital, AinZara, Tripoli
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ljms.ljms_1_22

Rights and Permissions

Background/Aims: Patients with preexisting morbidities (e.g., malignancy, posttransplant, and heart failure) are recognized to be at increased risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, as well as increased risk of mortality after infection. However, there are conflicting data on the susceptibility and prevalence of infection among people living with HIV (PLWH), with higher, lower, and equal prevalence to the general population were reported. The aim of this study was to assess the prevalence of SARS-CoV-2 antibodies among PLWH who are attending clinical care at the Department of Infectious Diseases of Tripoli University Hospital. Materials and Methods: A cross-sectional study conducted during the period from October 01, 2021 to December 01, 2021 at the (Department of Infectious Diseases) outpatient clinic of Tripoli University Hospital. The OnSite Coronavirus Disease 2019 IgG/IgM Rapid Test (CTK Biotech, San Diego County, California, USA) was used to determine the presence of antibodies against the spike protein of SARS-CoV-2 in the collected serum samples. The test results were reported as “Negative” or “Positive” as per the manufacturer's instructions. Results: A total of 108 PLWH were included in the study. Sixty-nine (64%) were male, and the mean age for participants was 44 years. Specific IgG/IgM antibodies for SARS-CoV-2 were detected in 31 individuals, representing a seroprevalence of 28.7%. Conclusions: High seroprevalence of SARS-CoV-2 antibodies among nonvaccinated PLWH attending clinical care at Tripoli University Hospital. They require pritorization on vaccination and boosting.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal